WebDisclosure WebDisclosure
Basculer en Français
11125 Companies
245019 Keywords
173082 Articles
132126 Press releases
Headlines Articles Press releases Geneyx Inc.; EpiSign Inc. Remove
  1. Home
  2. Companies
  3. Geneyx Inc.; EpiSign Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/05/2026 at 15:55, 1 hour 49 minutes ago

    EpiSign and Geneyx Unite for Genomic and Epigenomic Advances in Rare Diseases

    Partnership Sequencing Technology Genomic Analysis Epigenomic Insights Rare Disease Diagnosis
  • BRIEF

    published on 10/05/2026 at 15:55, 1 hour 49 minutes ago

    EpiSign et Geneyx s'unissent pour faire progresser la génomique et l'épigénomique dans les maladies rares

    Partenariat Analyse Génomique Perspectives Épigénomiques Diagnostic Des Maladies Rares Technologie De Séquençage
  • PRESS RELEASE

    published on 10/05/2026 at 15:50, 1 hour 54 minutes ago

    EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

    EpiSign and Geneyx partner to integrate genomic and epigenomic analysis for rare diseases, combining expertise in DNA methylation with multi-omics capabilities
    Rare Disease Genomic EpiSign Geneyx Epigenomic
    Logo of Geneyx Inc.; EpiSign Inc.
Accesswire
  • Published on 10/05/2026 at 14:45, 2 hours 59 minutes ago

    NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

  • Published on 10/05/2026 at 14:30, 3 hours 14 minutes ago

    Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology

  • Published on 10/05/2026 at 14:30, 3 hours 14 minutes ago

    Solitario CEO to Present at John Tumazos Very Independent Research, LLC

  • Published on 10/05/2026 at 14:00, 3 hours 44 minutes ago

    Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth

  • Published on 10/05/2026 at 14:00, 3 hours 44 minutes ago

    GameSquare to Present at Upcoming Investor Conferences

View all ACCESSWIRE
EQS Group
  • Published on 10/05/2026 at 17:07, 36 minutes ago

    Amprion successfully issues more green bonds worth EUR 1.5 billion

  • Published on 10/05/2026 at 15:50, 1 hour 54 minutes ago

    EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease

  • Published on 10/05/2026 at 15:49, 1 hour 54 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Senior PLC

  • Published on 10/05/2026 at 15:47, 1 hour 57 minutes ago

    BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 30.09.26.

  • Published on 10/05/2026 at 15:43, 2 hours 1 minute ago

    Form 8.3 - The Vanguard Group, Inc.: easyJet PLC

View all EQS
Les Echos
  • Published on 10/05/2026 at 17:40, 4 minutes ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 21 au 25 septembre 2026 dans le cadre du programme de rachat d’actions.

  • Published on 10/05/2026 at 17:18, 25 minutes ago

    voting rights

  • Published on 10/05/2026 at 17:18, 25 minutes ago

    droits de vote

  • Published on 10/05/2026 at 16:21, 1 hour 22 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from September 28 to October 2, 2026

  • Published on 10/05/2026 at 16:21, 1 hour 22 minutes ago

    Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 28 septembre au 2 octobre 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy